RESTON, Virginia, Oct. 26 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging posted the following news release:

* * *

Late-Breaking: Novel Alpha Radiopharmaceutical Therapy Shows Promising Activity in Phase 1 Prostate

*

Reston, VA (October 26, 2026)--A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed encouraging s . . .

Click here for more information about our products